Table V.
Results of breast cancer T staging in US and MRI.
| Pathological T staging | US consistent with pathology, n (%) | MRI consistent with pathology, n (%) | US combined with MRI consistent with pathology, n (%) | χ2 value | P-value |
|---|---|---|---|---|---|
| T1 (n=13) | 7 (53.85) | 10 (76.92) | 11 (84.62) | 3.292 | 0.193 |
| T2 (n=72) | 50 (69.44) | 62 (86.11)a | 64 (88.89)a,b | 10.550 | 0.005 |
| T3 (n=44) | 39 (88.64) | 42 (95.45) | 43 (97.73) | 4.827 | 0.090 |
| T4 (n=11) | 11 (100.00) | 11 (100.00) | 11 (100.00) | – | – |
| Total (n=140) | 107 (76.43) | 125 (89.29)a | 129 (92.14)a,b | 16.250 | <0.001 |
a
P<0.05 compared with US in the same T staging.
b
P<0.05 compared with MRI in the same T staging.